The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer
Abstract
Pharmacologists have realized that tyrosine kinase inhibitors (TKI) have potential as anti-cancer agents, both in prevention and therapy protocols. Nonetheless, concern about the risk of toxicity caused by synthetic TKIs restricted their development as chemoprevention agents. However, a naturally occurring TKI (the isoflavone genistein) in soy was discovered in 1987. The concentration of genistein in most soy food materials ranges from 1-2 mg/g. Oriental populations, who have low rates of breast and prostate cancer, consume 20-80 mg of genistein/day, almost entirely derived from soy, whereas the dietary intake of genistein in the US is only 1-3 mg/day. Chronic use of genistein as a chemopreventive agent has an advantage over synthetic TKIs because it is naturally found in soy foods. It could be delivered either in a purified state as a pill (to high-risk, motivated patient groups), or in the form of soy foods or soy-containing foods. Delivery of genistein in soy foods is more economically viable ($1.50 for a daily dose of 50 mg) than purified material ($5/day) and would require no prior approval by the FDA. Accordingly, investigators at several different sites have begun or are planning chemoprevention trials using a soy beverage product based on SUPRO, an isolated soy protein manufactured by Protein Technologies International of St. Louis, MO. These investigators are examining the effect of the soy beverage on surrogate intermediate endpoint biomarkers (SIEBs) in patients at risk for breast and colon cancer, defining potential SIEBs in patients at risk for prostate cancer, and determining whether the soy beverage reduces the incidence of cancer recurrence.(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
Cancer: Principles and Practice of Oncology.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-506_5 · Cited by 1,900
Soy intake and cancer risk: A review of the in vitro and in vivo data
Messina, M. J., Persky, V., Setchell, K. D. R., & Barnes, S. (1994) · Nutrition and Cancer · doi:10.1080/01635589409514310 · Cited by 1,315
Self-citationIsoflavone Content in Commercial Soybean Foods
Wang, H., & Murphy, P. A. (1994) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00044a016 · Cited by 996
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County
Shimizu, H., Ross, R., Bernstein, L., Yatani, R., Henderson, B., & Mack, T. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.210 · Cited by 890
Coward, L., Barnes, N. C., Setchell, K. D. R., & Barnes, S. (1993) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00035a027 · Cited by 882
Self-citationGenistein, a dietary-derived inhibitor of in vitro angiogenesis.
Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., & Schweigerer, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2690 · Cited by 766
Dietary effects on breast-cancer risk in Singapore
Lee, H. P., Lee, J., Gourley, L., Duffy, S. W., Day, N. E., & Estève, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)92867-2 · Cited by 765
Western diet and Western diseases: Some hormonal and biochemical mechanisms and associations
Adlercreutz, H. (1990) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519009085798 · Cited by 761
Adlercreutz, H., Honjo, H., Higashi, A., Fotsis, T., Hämäläinen, E., Hasegawa, T., & Okada, H. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.6.1093 · Cited by 656
Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease
Setchell, K. D., Borriello, S. P., Hulme, P., Kirk, D. N., & Axelson, M. (1984) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/40.3.569 · Cited by 619
The Role of Soy Products in Reducing Risk of Cancer
Messina, M., & Barnes, S. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.8.541 · Cited by 601
Self-citationInhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.
Markovits, J., Linassier, C., Fossé, P., Couprie, J., Pierre, J., Jacquemin‐Sablon, A., Saucier, J.-M., Pecq, J. B. L., & Larsen, A. K. (1989) · PubMed · Cited by 550
Dietary fat and the risk of breast cancer.
Willett, W. C., Stampfer, M. J., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Speizer, F. E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701013160105 · Cited by 534
Daidzein Is a More Bioavailable Soymilk Isoflavone than Is Genistein in Adult Women
Xu, X., Wang, H.-J., Murphy, P. A., Cook, L., & Hendrich, S. (1994) · The Journal of Nutrition · doi:10.1093/jn/124.6.825 · Cited by 508
Antioxidant and Antipromotional Effects of the Soybean Isoflavone Genistein
Wei, H., Bowen, R., Cai, Q., Barnes, S., & Wang, Y. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-208-43844 · Cited by 506
Self-citationCancer: Principles and Practice of Oncology
Gunn, W. G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03370070111039 · Cited by 493
Okura, A., Arakawa, H., Oka, H., Yoshinari, T., & Monden, Y. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80030-5 · Cited by 437
Peterson, G., & Barnes, S. (1993) · The Prostate · doi:10.1002/pros.2990220408 · Cited by 412
Self-citationDietary Fat and Fiber in Relation to Risk of Breast Cancer: An 8-Year Follow-up
Willett, W. C. (1992) · JAMA · doi:10.1001/jama.1992.03490150089030 · Cited by 389
Carcinogen-mediated oxidant formation and oxidative DNA damage
Frenkel, K. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90047-4 · Cited by 379
Effect of Genistein on In Vitro and In Vivo Models of Cancer
Barnes, S. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.3_suppl.777s · Cited by 364
Self-citationInhibition of tumor Promoter‐induced hydrogen peroxide formation in vitro and in vivo by genistein
Wei, H., Wei, L., Frenkel, K., Bowen, R., & Barnes, S. (1993) · Nutrition and Cancer · doi:10.1080/01635589309514265 · Cited by 359
Self-citationBarnes, S. H., KIRK, M. C., & Coward, L. U. (1994) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00047a019 · Cited by 354
Self-citationYanagihara, K., Ito, A., Toge, T., & Numoto, M. (1993) · PubMed · Cited by 322
Martinez, M. (1963) · PubMed · Cited by 296
Genistein arrests cell cycle progression at G2-M
松川, 義. (1995) · Medical Entomology and Zoology · Cited by 295
Soybeans inhibit mammary tumors in models of breast cancer.
Barnes, S., Grubbs, C., Setchell, K. D. R., & Carlson, J. (1990) · PubMed · Cited by 258
Self-citationNeonatal Genistein Chemoprevents Mammary Cancer
Lamartiniere, C. A., Moore, J., Holland, M., & Barnes, S. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-208-43843 · Cited by 243
Self-citationMutagens and Carcinogens in the Diet
Weisburger, J. H. (1991) · Journal of the American College of Nutrition · doi:10.1080/07315724.1991.10738181 · Cited by 238
Constantinou, A. I., Kiguchi, K., & Huberman, E. (1990) · PubMed · Cited by 223
Pereira, M. A., Barnes, L. H., Rassman, V. L., Kelloff, G. V., & Steele, V. E. (1994) · Carcinogenesis · doi:10.1093/carcin/15.5.1049 · Cited by 219
Dunn, J. E. (1975) · PubMed · Cited by 217
Yoshinori, Y., Sho-Zou, K., & Hirofumi, N. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90153-c · Cited by 215
Lipid Risk factors and Atherosclerosis: What do We Measure?
Stein, E. A. (1990) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519009091078 · Cited by 214
Spinozzi, F., Pagliacci, M. C., Migliorati, G., Moraca, R., Grignani, F., Riccardi, C., & Nicoletti, I. (1994) · Leukemia Research · doi:10.1016/0145-2126(94)90079-5 · Cited by 214
Antioxidant and antiproliferative effect of the soybeen isoflavone genistein
Wei, H. (1995) · Medical Entomology and Zoology · Cited by 205
Adlercreutz, H., Fotsis, T., Bannwart, C., Wähälä, K., Brunow, G., & Hase, T. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90120-2 · Cited by 198
Gray, G. E., Pike, M. C., & Henderson, B. E. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.1 · Cited by 194
Traganos, F., Ardelt, B. K., Halko, N., Bruno, S., & Darżynkiewicz, Z. (1992) · PubMed · Cited by 165
Carson, W. E., Haldar, S., Baiocchi, R. A., Croce, C. M., & Caligiuri, M. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7553 · Cited by 147
Soybean diet lowers breast tumor incidence in irradiated rats
Troll, W., Wiesner, R., Shellabarger, C. J., Holtzman, S., & Stone, J. P. (1980) · Carcinogenesis · doi:10.1093/carcin/1.6.469 · Cited by 136
Potential Role of Dietary Isoflavones in the Prevention of Cancer
Barnes, S., Peterson, G., Grubbs, C. J., & Setchell, K. D. R. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0939-8_10 · Cited by 111
Self-citationA specific inhibitor for tyrosine protein kinase from Pseudomonas.
Ogawara, H., Akiyama, T., ISHIDA, J., WATANABE, S.-I. I., & Suzuki, K. (1986) · The Journal of Antibiotics · doi:10.7164/antibiotics.39.606 · Cited by 102
Robinson, M. J., Corbett, A. H., & Osheroff, N. (1993) · Biochemistry · doi:10.1021/bi00065a016 · Cited by 94
Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines.
Bergamaschi, G., Rosti, V., Danova, M., Ponchio, L., Lucotti, C., & Cazzola, M. (1993) · PubMed · Cited by 86
McNicol, A. (1993) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(93)90118-g · Cited by 44
Hunáková, Ľ., Sedlák, J., Klobušická, M., Duraj, J., & Chorvath, B. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90168-6 · Cited by 17
Cited by
Phyto-oestrogens and Western Diseases
Adlercreutz, H., & Mazur, W. (1997) · Annals of Medicine · doi:10.3109/07853899709113696 · Cited by 1,279
Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412401 · Cited by 1,191
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Tham, D. M., Gardner, C. D., & Haskell, W. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4752 · Cited by 714
Human prostate cancer risk factors
Bostwick, D. G., Burke, H. B., Djakiew, D., Euling, S., Ho, S.-M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D. J., et al. (2004) · Cancer · doi:10.1002/cncr.20408 · Cited by 650
Metadata
- Authors
- Barnes, S., Peterson, T. G., & Coward, L.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 1995
- Volume
- 59
- Issue
- S22
- Pages
- 181-187
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2123393698
- Cited by
- 257
- References
- 49
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.